Effects of a Dietary Supplement Containing L-Arabinose and Trivalent Patented Food-source of Chromium on Blood Glucose and Insulin
- Conditions
- Pre-diabetes
- Registration Number
- NCT01107431
- Lead Sponsor
- Integrative Health Technologies, Inc.
- Brief Summary
This study was designed to examine changes in capillary blood glucose and venous insulin levels after a 70 gram oral sucrose challenge with and without simultaneous consumption of a dietary supplement containing L-Arabinose and a patented version of chromium (LA-Cr).
- Detailed Description
This study concluded that consumption of the LA-Cr supplement in conjunction with a 70-gram sucrose challenge led to a significant reduction of capillary blood glucose and venous insulin as compared to the sucrose challenge without the LA-Cr supplement. This finding may provide an important tool to reduce the adverse effects associated with elevated glucose and insulin levels.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 70
- All study subjects were required to contact their family physician to ensure they had no medical conditions that would preclude their participation.
- Diabetics, and
- Those not approved by their physicians.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Fasting Blood Glucose Every 15 to 30 minutes Finger-stick glucose measurements taken every 15 or 30 minutes after taking a 70 gram sucrose challenge with and without the dietary supplement
- Secondary Outcome Measures
Name Time Method Fasting Blood Insulin Levels Every 30 minutes A venipuncture blood test taken 30, 60, 90 and 120 minutes after taking a 70 gram sucrose challenge with and without taking the dietary supplement
Trial Locations
- Locations (1)
Integrative Health Technologies
🇺🇸San Antonio, Texas, United States
Integrative Health Technologies🇺🇸San Antonio, Texas, United States